Effect of PALB2 status on breast cancer precision medicine

Lancet Oncol. 2015 Jun;16(6):598-600. doi: 10.1016/S1470-2045(15)70182-8. Epub 2015 May 7.

Authors

Suzette Delaloge¹, Olivier Caron², Jean Feunteun³

Affiliations

¹ Department of Breast Oncology, Gustave Roussy Institute, Villejuif, France; INSERM UMR 981, Gustave Roussy Institute, Villejuif, France. Electronic address: suzette.delaloge@gustaveroussy.fr.
² Department of Genetics, Gustave Roussy Institute, Villejuif, France.
³ INSERM UMR 981, Gustave Roussy Institute, Villejuif, France; Laboratory of Genetic Stability and Tumorigenesis UMR 8200; Gustave Roussy Institute, Villejuif, France.

PMID: 25959804
DOI: 10.1016/S1470-2045(15)70182-8

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms / genetics*
Female
Genetic Predisposition to Disease*
Humans
Nuclear Proteins / genetics*
Tumor Suppressor Proteins / genetics*

Substances

Nuclear Proteins
Tumor Suppressor Proteins